Extended Exposure Topotecan Significantly Improves Long-Term Drug Sensitivity by Decreasing Malignant Cell Heterogeneity and by Preventing Epithelial–Mesenchymal Transition
Maximum tolerable dosing (MTD) of chemotherapeutics has long been the gold standard for aggressive malignancies. Recently, alternative dosing strategies have gained traction for their improved toxicity profiles and unique mechanisms of action, such as inhibition of angiogenesis and stimulation of im...
Main Authors: | Joshua T. Davis, Taraswi Mitra Ghosh, Suman Mazumder, Amit Mitra, Richard Curtis Bird, Robert D. Arnold |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2023-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/24/10/8490 |
Similar Items
-
Identification and Characterization of Key Differentially Expressed Genes Associated With Metronomic Dosing of Topotecan in Human Prostate Cancer
by: Taraswi Mitra Ghosh, et al.
Published: (2021-12-01) -
Effect of <i>ALDH1A1</i> Gene Knockout on Drug Resistance in Paclitaxel and Topotecan Resistant Human Ovarian Cancer Cell Lines in 2D and 3D Model
by: Marta Nowacka, et al.
Published: (2022-03-01) -
Therapeutic uses of topotecan for thoracic malignancies
by: Saoirse O. Dolly, et al.
Published: (2011-12-01) -
Crotoxin Modulates Events Involved in Epithelial–Mesenchymal Transition in 3D Spheroid Model
by: Ellen Emi Kato, et al.
Published: (2021-11-01) -
FOXA2 suppresses endometrial carcinogenesis and epithelial-mesenchymal transition by regulating enhancer activity
by: Subhransu S. Sahoo, et al.
Published: (2022-06-01)